对间歇性肺部疾病急性恶化的临床试验
Panagiota Tsiri1, Fabiola Murgolo2, Bruno Crestani1,2
1UMR 1149, Centre de recherche de l'inflammation, Université Paris Cité, Paris, France.
Expert review of respiratory medicine
|June 17, 2025
概括
间歇性肺部疾病的急性恶化是一个主要的挑战. 与无效的免疫抑制剂不同,像宁泰达尼布和皮尔费尼这样的抗纤维菌药物显示出预防性益处.
科学领域:
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 间歇性肺部疾病 (ILD) 的急性恶化,特别是异常性肺纤维化 (IPF),带来了重大的临床挑战和高死亡率.
- 传统的经验性免疫抑制疗法,包括环胺,在治疗这些恶化症方面表现出缺乏有效性.
研究的目的:
- 审查最近的随机临床试验数据,涉及ILDs的急性恶化.
- 评估各种治疗策略的有效性,包括抗纤维素药物和以前使用的药物.
- 讨论目前临床试验设计中的诊断挑战和方法限制.
主要方法:
- 使用PubMed和ClinicalTrials.gov (NCT) 数据库进行了全面的文献搜索.
- 收集了2025年3月之前发表的研究数据.
- 该审查重点关注ILDs急性恶化随机临床试验结果.
主要成果:
- 环胺和复合血栓模块素在治疗急性恶化时显示出负面结果.
- 抗纤维素药物,如宁泰达尼布和皮尔芬尼,显示出积极的预防作用.
- 还考虑了有关疫苗接种策略的证据,以及试验设计的限制.
结论:
- 临床实践应该从无效的疗法过渡到精准医学,结合生物标志物和预防性抗纤维菌策略.
- 新的治疗目标和国际研究合作对于改善ILD患者的治疗结果至关重要.
- 抗纤维素药物是预防ILDs急性恶化的一个有希望的途径.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:16Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
331
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
331
01:20COPD: Pathogenesis and Clinical Features
544
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
544
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K